Replies to post #9002 on Cytogenix (fka CYGX)

[lawrenceolivier]

ECMorgan:
The stockholder news was nothing new. The delivery problem is still a problem. The financing issue is still unresolved. The SP will not move in a positive direction until these issues are resolved. I'm still buying more shares when the price hits around 25 cents a share.